Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tuberculosis contact investigation: tuberculin skin test alone versus tuberculin skin test plus QuantiFERON-TB Gold In-Tube
2009-017430-49Phase 4Completed
- Sponsor
- Dr Miguel SantÃn Cerezales
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of isoniazid and rifampicin in latent tuberculosis infection (LTBI) and Tuberculosis (TB) (2 arms), sponsored by Dr Miguel SantÃn Cerezales. Primary endpoint: Difference in incidence of tuberculosis disease. Started Dec 2009; status: completed.
02
Drugs
isoniazidrifampicin
03
Conditions
latent tuberculosis infection (LTBI)Tuberculosis (TB)
Beyond the preview
Go deeper on 2009-017430-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017430-49.